View Author
stent patient strut month follow-up scaffold lesion study vessel 6 months analysis artery diameter trial implantation change lumen 2 years plaque group result serruy device ultrasound everolimu intravascular baseline value imaging signi tissue everolimus-eluting angiographic table bioresorbable intervention segment curvature procedure coherence tomography 6- month follow-up cohort angiography angulation calcium stenosi serruys pw recoil calci vessel wall 2 year follow-up abbott bioabsorbable system reduction calci fied group method image neointimal restenosi 12 months target assessment lumen area difference intravascular ultrasound figure scaffold area balloon echogenicity population process coherence ficant cardiol polymer spirit hyperechogenicity tomography noncalci fied group
10 Most Recent Publications
|
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography
(Article)
Gomez-Lara, J. Brugaletta, S. Dudek, D. Smits, P.C. Chevalier, B. Regar, E.S. Veldhof, S. Rapoza, R. Ormiston, J.A. Garcia-Garcia, H.M. Serruys, P.W.J.C. Farooq, V. Onuma, Y. Diletti, R. Windecker, S. Thuesen, L. McClean, D. Koolen, J. Whitbourn, R. |
2011-12-01
|
|
Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12 months after implantation: Insights from the ABSORB B trial
(Article)
Brugaletta, S. Gomez-Lara, J. Windecker, S. Smits, P.C. Bruyne, B. de Whitbourn, R. Meredith, I. Domburg, R.T. van Sihan, K. Winter, S. de Veldhof, S. Miquel-Hébert, K. Serruys, P.W.J.C. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Bruining, N. Farooq, V. Geuns, R-J.M. van Thuesen, L. Dudek, D. Koolen, J. Chevalier, B. McClean, D. |
2011-12-01
|
|
Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold
(Article)
Brugaletta, S. Gomez-Lara, J. Whitbourn, R. Meredith, I. Dorange, C. Veldhof, S. Rapoza, R. Ormiston, J.A. Serruys, P.W.J.C. Garcia-Garcia, H.M. Heo, J.H. Farooq, V. Geuns, R-J.M. van Chevalier, B. Windecker, S. McClean, D. Thuesen, L. |
2011-11-24
|
|
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de Novo Coronary Artery stenosis: 12-month clinical and imaging outcomes
(Article)
Serruys, P.W.J.C. Onuma, Y. Windecker, S. Whitbourn, R. Meredith, I. Dorange, C. Veldhof, S. Hebert, K.M. Sudhir, K. Garcia-Garcia, H.M. Ormiston, J.A. Dudek, D. Smits, P.C. Koolen, J. Chevalier, B. Bruyne, B. de Thuesen, L. McClean, D. Geuns, R-J.M. van |
2011-10-04
|
|
Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography
(Article)
Gomez-Lara, J. Radu, M. Whitbourn, R. Dudek, D. Smits, P.C. Regar, E.S. Veldhof, S. Rapoza, R. Ormiston, J.A. Garcia-Garcia, H.M. Serruys, P.W.J.C. Brugaletta, S. Farooq, V. Diletti, R. Onuma, Y. Windecker, S. Thuesen, L. McClean, D. Koolen, J. |
2011-09-01
|
|
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm
(Article)
Diletti, R. Onuma, Y. Chevalier, B. McClean, D. Windecker, S. Whitbourn, R. Smits, P.C. Koolen, J. Meredith, I. Li, D. Veldhof, S. Rapoza, R. Farooq, V. Garcia-Garcia, H.M. Ormiston, J.A. Serruys, P.W.J.C. Gomez-Lara, J. Brugaletta, S. Geuns, R-J.M. van Regar, E.S. Bruyne, B. de Dudek, D. Thuesen, L. |
2011-07-12
|
|
Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent
(Article)
Onuma, Y. Serruys, P.W.J.C. Windecker, S. Whitbourn, R. Meredith, I. Garcia-Garcia, H.M. Ormiston, J.A. Gomez, J. Bruyne, B. de Dudek, D. Thuesen, L. Smits, P. Chevalier, B. McClean, D. Koolen, J. |
2011-07-01
|
|
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up
(Article)
Gomez-Lara, J. Brugaletta, S. Whitbourn, R. Smits, P.C. Chevalier, B. Morel, M-A.M. Dorange, C. Veldhof, S. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Serruys, P.W.J.C. Farooq, V. Geuns, R-J.M. van Bruyne, B. de Windecker, S. McClean, D. Thuesen, L. Dudek, D. Koolen, J. |
2011-07-01
|
|
Morphological and functional evaluation of the bioresorption of the bioresorbable everolimus-eluting vascular scaffold using IVUS, echogenicity and vasomotion testing at two year follow-up: a patient level insight into the ABSORB A clinical trial
(Article)
Sarno, G. Bruining, N. Dorange, C. Garcia-Garcia, H.M. Ormiston, J.A. Serruys, P.W.J.C. Onuma, Y. Garg, S.A. Brugaletta, S. Winter, S. de Regar, E.S. Thuesen, L. Dudek, D. Veldhof, S. |
2010-12-01
|
|
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: Six-month clinical and imaging outcomes
(Article)
Serruys, P.W.J.C. Onuma, Y. Koolen, J. Windecker, S. Whitbourn, R. Meredith, I. Dorange, C. Veldhof, S. Miquel-Hébert, K. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Bruyne, B. de Regar, E.S. Dudek, D. Thuesen, L. Smits, P.C. Chevalier, B. McClean, D. |
2010-11-30
|